• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu
VIEW ALL RESEARCH-GROUP

Susceptibility, tumor progression and resistance
Pujana’s Lab

DESCRIPTION

Targeting cancer complexity at origin and progression

Our research is focused on better understanding breast cancer initiation and, from acquired knowledge, to assess targeted prevention strategies. In parallel, we study pan-cancer vulnerabilities and the connection to a rare, lung metastatic disease, lymphangioleiomyomatosis (LAM).

Group members

Miquel Angel Pujana

Group leaders

Principal investigator

Francesca Mateo

Researchers

Research assistant

Roderic Espín

Young investigators

PhD student

Lara Ruiz

Young investigators

PhD student

Arzoo Shabbir

Young investigators

PhD student

    Luís Alfaro

    Young investigators

    PhD student

    Publications

    Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

    12 de March de 2019/in Pujana's Lab/by miguel

    NPJ Syst Biol Appl. 2019 Mar 1;5:7. doi: 10.1038/s41540-019-0087-2. eCollection 2019. ABSTRACT In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Alterations in […]

    https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-03-12 10:00:002019-03-12 10:00:00Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

    Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1

    17 de February de 2019/in Pujana's Lab/by miguel

    Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4326-4335. doi: 10.1073/pnas.1819473116. Epub 2019 Feb 15. ABSTRACT The combination of immune checkpoint blockade with chemotherapy is currently under investigation as a promising strategy for the treatment of triple negative breast cancer (TNBC). Tumor-associated macrophages (TAMs) are the most prominent component of the breast cancer microenvironment […]

    https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-02-17 11:00:002019-02-17 11:00:00Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1

    Evolutionary Changes after Translational Challenges Imposed by Horizontal Gene Transfer

    13 de February de 2019/in Pujana's Lab/by miguel

    Genome Biol Evol. 2019 Mar 1;11(3):814-831. doi: 10.1093/gbe/evz031. ABSTRACT Genes acquired by horizontal gene transfer (HGT) may provide the recipient organism with potentially new functions, but proper expression level and integration of the transferred genes in the novel environment are not granted. Notably, transferred genes can differ from the receiving genome in codon usage preferences, […]

    https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-02-13 11:00:002019-02-13 11:00:00Evolutionary Changes after Translational Challenges Imposed by Horizontal Gene Transfer

    AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer

    9 de February de 2019/in Pujana's Lab/by miguel

    Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3604-3613. doi: 10.1073/pnas.1815126116. Epub 2019 Feb 7. ABSTRACT Cancer cells have higher reactive oxygen species (ROS) than normal cells, due to genetic and metabolic alterations. An emerging scenario is that cancer cells increase ROS to activate protumorigenic signaling while activating antioxidant pathways to maintain redox homeostasis. […]

    https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2019-02-09 11:00:002019-02-09 11:00:00AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer

    Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness

    13 de November de 2018/in Pujana's Lab/by miguel

    PLoS One. 2018 Nov 12;13(11):e0207586. doi: 10.1371/journal.pone.0207586. eCollection 2018. ABSTRACT [This corrects the article DOI: 10.1371/journal.pone.0132546.]. PMID:30419005 | PMC:PMC6231678 | DOI:10.1371/journal.pone.0207586

    https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2018-11-13 11:00:002018-11-13 11:00:00Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness
    Page 12 of 23«‹1011121314›»

    Research Projects

    The group works and collaborates to decipher the systems mechanisms of cancer development and progression, with the aim of developing more precise preventive and therapeutic approaches. The group combines in silico and wet-lab studies for the purpose of identifying cancer principles and vulnerabilities.

    Collaborations

    CIMBA – Consortium of Investigators of Modifiers of BRCA1/2

    https://cimba.ccge.medschl.cam.ac.uk/

    Lobular Breast Cancer

    https://lobsterpot.eu/

    BRCA1 breast cancer

    Khokha Lab

    https://medbio.utoronto.ca/faculty/khokha

    Hakem Lab

    https://medbio.utoronto.ca/faculty/hakem

    Maxwell Lab

    https://www.bcchr.ca/cmaxwell

    Serra Lab

    https://vhio.net/biosketch-violeta-serra/

    Cancer biology

    Schramek Lab

    https://schramek.lunenfeld.ca/

    Li Lab

    https://lilab.smhs.gwu.edu/

    Barcellos-Hoff Lab

    https://barcelloshofflab.ucsf.edu/principal-investigator

    Cancer genetics

    De Cid Lab – GCAT

    http://www.gcatbiobank.org/

    LAM research

    Johnson Lab – LAM UK

    https://www.nottingham.ac.uk/medicine/people/simon.johnson

    Elżbieta Radzikowska

    National Tuberculosis and Lung Diseases Research Institute, Poland

    Kwiatkowski Lab

    https://www.kwiatkowskilab.org/

    AELAM

    https://www.aelam.org/

    VHIR

    https://vhir.vallhebron.com/en/research/pneumology

    Molina Lab

    https://idibell.cat/en/research/translational-medicine-area/cardiovascular-respiratory-and-systemic-diseases-and-cellular-aging-program/pneumology/

    Research group photo.Pujana's Lab
    Program Against Cancer Therapeutic Resistance

    CONTACT US

    Campus IDIBELL
    (L’Hospitalet del Llobregat)
    Hospital Duran i Reynals, Gran Via 199,
    L’Hospitalet del Llobregat,
    Barcelona 08908
    Tel. +34 93 260 7952

    Campus IGTP-IJC
    (Badalona)
    Campus Can Ruti – IGTP – Building Muntanya,
    Rd. Can Ruti, Camí de les escoles s/n,
    Badalona, Barcelona 08916
    Tel. +34 93 554 3069

    Campus IDIBGI
    (Girona)
    Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
    Salt, Girona 17190
    Tel. +34 872 987 087

    © Copyright - Edisenius
    • Privacy Policy
    • Cookie Policy
    • Legal Notice
    Belver’s LabBelver's LabMenendez's LabMenendez’s Lab
    Scroll to top
    Manage cookie consent
    To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
    Functional Always active
    Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
    Marketing
    Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    See preferences
    {title} {title} {title}